Latest News

  • GeneCapture Receives DOD Contract For Portable Pathogen Diagnostic Platform

    Diagnostics World | GeneCapture, a diagnostics company based at the HudsonAlpha Institute for Biotechnology in Huntsville, Ala., announced a two-year, $1 million Small Business Technology Transfer Research contract from the U.S. Department of Defense’s Defense Threat Reduction Agency (DTRA).

    Jun 20, 2018

  • Alexion’s Quest To Test The Algorithm Of Rare Disease Diagnosis

    Diagnostics World | Alexion, in collaboration with EPAM, has developed a software competition platform to allow the objective comparison of contributed algorithms for automated rare disease diagnosis.

    Jun 19, 2018

  • Rare Genomics Institute Announces Winners Of BeHEARD 2018 Rare Disease Challenge

    Diagnostics World Brief | The Rare Genomics Institute is delighted to announce the winners of the 2018 BeHEARD (Helping Empower and Accelerate Research Discoveries) science challenge, a global competition that offers rare disease researchers, who traditionally have difficulty attracting funding, grants of the latest life science innovations and technologies.

    Jun 14, 2018

  • Developing Low Cost Diagnostics For Infectious Disease

    Diagnostics World | Podcast | Paul Yager of University of Washington is featured on this podcast from Cambridge Health Tech Institute for the Next Generation Diagnostic Summit. Yager speaks about his lab’s success in developing NAAT testing, obstacles to developing low cost diagnostics, and advice for those looking to get into the field.

    Jun 13, 2018

  • New Study Launched To Identify Women At High Risk Of Preterm Birth, Most Effective Interventions

    Diagnostics World Brief | Researchers are launching the first study of its kind involving up to 10,000 women that will use a new test to identify those at risk for premature birth, and, in those with high risk, to evaluate the impact of early interventions designed to prolong their pregnancy and reduce the rate of premature delivery.

    Jun 12, 2018

  • New $100 Genetic Test Identifies Men Who Have Vastly Increased Chance Of Developing Prostate Cancer

    Forbes | A new saliva-based test for prostate cancer can identify men at increased risk of developing the disease at a cost of less than $100.

    Jun 11, 2018

  • Skin In The Game

    Diagnostics World | While the gut may be a central location for many of our microbes, trillions of bacteria, fungi, and viruses reside all over our bodies. They live in our mouths, inhabit our noses, and even populate the surface of our largest organ. So some researchers are taking aim at the skin microbiome.

    Jun 6, 2018